Details for New Drug Application (NDA): 212474
✉ Email this page to a colleague
The generic ingredient in ELIGLUSTAT TARTRATE is eliglustat tartrate. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the eliglustat tartrate profile page.
Summary for 212474
Tradename: | ELIGLUSTAT TARTRATE |
Applicant: | Teva Pharms Usa Inc |
Ingredient: | eliglustat tartrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 84MG BASE | ||||
Approval Date: | Dec 27, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription